Nonopioid pain prescriptions increased after 2016 CDC guideline, study finds

Researchers say the findings suggest more clinicians are carefully considering the risks of prescribing opioids.

5:00 AM

Author | Noah Fromson

prescription pad
Jacob Dwyer, Justine Ross, Michigan Medicine

Researchers say the findings suggest more clinicians are carefully considering the risks of prescribing opioids.

After the Centers for Disease Control and Prevention released a guideline for prescribing opioids to patients experiencing chronic pain in 2016, the prescribing rate of nonopioid pain medication increased each year above and beyond what would be expected based on the preexisting trends, a study finds.

The 2016 guideline aimed to help United States clinicians treat adult patients for chronic pain while weighing the benefits and risks of prescribing opioids, as more Americans died of opioid-related overdose. Using insurance claims data from over 15 million patients, a team of researchers from Michigan Medicine and the CDC analyzed the prescribing rates of nonopioid pain medications, such as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs). 

They found that the odds of prescribing a nonopioid pain medication in 2016 were 3% higher than expected from pre-guideline estimates for the same year. That number increased to 8% in 2017 and 9.7% in 2018. The results are published in JAMA Network Open.

SEE ALSO: Could time limits on opioid prescriptions reduce misuse? 

"These findings suggest that clinicians have been prescribing nonopioid pain medications more frequently since the 2016 guideline was released, and that may mean that they've considered opioid therapy only if its expected benefits exceeded the expected risks to the patient," said Jason Goldstick, Ph.D., lead author of the study and a research associate professor of emergency medicine at University of Michigan Medical School.

"Though many characteristics – such as pain intensity and effectiveness of pain management – are not available in these data, these results may represent an increase in guideline-concordant pain treatment."

The increase in nonopioid pain medication prescribing coincided with a significant drop in opioid prescribing over the same period, consistent with other research showing reductions in opioid prescribing following the 2016 guideline release. Increases in nonopioid pain medication prescribing were consistent across several patient subpopulations, including those with recent opioid exposure, as well as those with anxiety or mood disorders.

SEE ALSO: Just over half of Michigan pharmacies offer overdose-fighting naloxone without prescription

"The 2016 guideline encouraged caution in prescribing opioids, and it was possible that it could have reduced the use of pain treatments overall," said Amy Bohnert, Ph.D., M.H.S., senior author of the paper and associate professor of psychiatry at U-M Medical School. "Our analysis provides an encouraging sign that patients were more often offered other treatments for pain than before the guideline, rather than only being offered opioids less often."

Researchers say the changes in prescribing may have also led to a shift toward the use of some nonpharmacologic treatments, including physical therapy and cognitive behavioral therapy. They note additional research on changes in nonpharmacologic pain treatments, as well as undertreatment of pain and patient pain outcomes, are needed to gain a fuller understanding of changes to the pain management landscape following the 2016 guideline release.

"Multimodal and multidisciplinary approaches to pain management that address the biological, psychological and social characteristics of each person are a critical part of a comprehensive treatment protocol," researchers wrote. "Further analysis can help identify the avenues through which pain relief can be optimized."

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.

Additional authors include Matthew G Myers, M.P.H., of Michigan Medicine, and Gery P. Guy, Ph.D., M.P.H., Jan L. Losby, Ph.D., M.S.W., and Grant T. Baldwin, Ph.D., M.P.H., all of the CDC

This work was funded in part by grant 19IPA1906094 (Dr Goldstick), U01CE002780 (Dr Bohnert), and R49CE003085 from the Centers for Disease Control and Prevention.

Paper cited: "Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain," JAMA Network Open. DOI: DOI: 10.1001/jamanetworkopen.2022.16475

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter


More Articles About: Lab Notes Addiction and Substance Abuse Community Health Acute Pain Health Care Quality Medication Guidelines Pain management
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Mott Poll teens and caffeine
Health Lab
Does your teen consume too much caffeine?
A quarter of parents report that caffeine is basically part of their teen’s daily life, according to a national poll.
pills floating blue pink dark background physician in middle looking at chart white coat scrubs
Health Lab
Better medical record-keeping needed to fight antibiotic overuse, studies suggest
Efforts to reduce overuse of antibiotics may be hampered by incomplete medical records that don’t show the full reasons for prescriptions.
surgery gloves passing tool blue and yellow
Health Lab
A universal heparin reversal drug is shown effective in mice
The newest version of the heparin reversal drug, described in a recent issue of Advanced Healthcare Materials, adjusted the number of protons bound to it, making the molecule less positive so it would preferentially bind to the highly negative heparin, resulting in a much safer drug.
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
doctor in white coat with dark blue scrubs touching hand of patient in grey sweater and baseball cap in exam room
Health Lab
Neuropathy common, and mostly undiagnosed, among patients in this Michigan city
A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.